Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea (OSA)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01685736
Verified September 2012 by George S. Stergiou, University of Athens. Recruitment status was: Recruiting
Subjects referred to a sleep clinic had polysomnography (PSG), clinic BP measurements, 24-hour ABP monitoring and HBP monitoring using a device (Microlife WatchBP HomeN) that allows daytime (3 days, 2 duplicate readings/day) and automated nighttime BP measurement (3 nights, 3 readings/night).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects referred to a sleep clinic
Age ≤ 65 years
Treated or untreated for hypertension
History of cardiovascular disease (heart failure, coronary heart disease, arrhythmia or stroke)
History of asthma or chronic obstructive pulmonary disease (FEV1/FVC <70%)
History of diabetes mellitus, collagen diseases and sarcoidosis
Serum creatinine >1.6 mg/dl, proteinuria
Previous treatment with CPAP
Pregnancy or menstruation during the study
Treatment with steroids, lithium or any other drugs affecting BP
Change in antihypertensive treatment(if any) in the last 8 weeks before study entry